All In MedTech

Device Trial Radar · NCT05317728

Clinical Study of a Fluid Accommodating Intraocular Lens (IOL) Design

Randomized Controlled Study of Fluid Accommodating IOL Outcomes Versus Monofocal Control

Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 175 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

175

Actual

Start

Mar 31, 2023

Primary completion

Nov 2026

Study completion Nov 2026

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Apr 8, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical study is to evaluate the surgical, refractive, and visual outcomes with implantation of an investigational intraocular lens (IOL).

Conditions

  • Cataract

Interventions

  • BAL-FAIOL IOLDevice

    Investigational implantable medical device intended for long-term use over the lifetime of the cataract subject

  • Monofocal IOLDevice

    Commercially available implantable medical device intended for long-term use over the lifetime of the cataract subject

  • Cataract surgeryProcedure

    Phacoemulsification with a clear cornea incision

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Photopic Monocular Best Corrected Distance Visual Acuity (BCDVA) (4 meters)Time frame: Month 6 post second eye implantation
  2. Cumulative Adverse Events, including Secondary Surgical Interventions (SSIs)Time frame: Up to Year 1
  3. Cumulative Adverse Events, including Secondary Surgical Interventions (SSIs) - Cohort 2Time frame: Up to Year 1

Locations

6 sites in 4 countries. Site status is shown where the registry gives one.

  • Clinica 20/20

    San José, Costa Rica

  • Laser Center SA

    Santo Domingo, Dominican Republic

  • Asociación Para Evitar la Ceguera en México

    Mexico City, Mexico

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.